About 3 results found for searched term "Angiopep-2 TFA" (0.134 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M13354 | Angiopep-2 TFA | Peptides |
| Angiopep-2 TFA is a brain peptide carrier. Binding of the antitumor compound to angiopEP-2 peptide carrier enhances its activity in brain cancer. Amino acid serial sequence: Thr-Phe-Phe-Tyr- GLly - Glly -Ser-Arg- GLly -Lys-Arg-Asn-Asn-Phe-Lys-Thr- glu-glu-TYr | ||
| M58450 | Angiopep-2-Cys TFA | Peptides |
| Angiopep-2-cys is a conjugate of Angiopep-2 hydrochloride and cysteine. The conjugation of anticancer agents with the Angiopep-2 peptide vector could increase their efficacy in the treatment of brain cancer. | ||
| M11321 | Angiopeptin TFA | Somatostatin Receptor |
| Angiopeptin TFA, a cyclic octapeptide analog of somatostatin, is an SST2 / SST5 receptor partial agonist with IC50 values of 0.26 nM and 6.92 nM, respectively. Angiopeptin TFA inhibits growth hormone release and insulin-like growth factor-1 (IGF-1) production. Angiopeptin TFA inhibits adenylate cyclase or stimulates extracellular acidification. Angiopeptin TFA has the potential to be used in the study of coronary atherosclerosis. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
